Male infertility is a complex disease, and genetic abnormalities are among the main causal factors for the disorder. Aim: In order to evaluate the proportion of the most common genetic factors in etiology of male infertility, examination for chromosomal abnormalities and microdeletions of Yq chromosome (delYq) was carried out in Bulgarian males with severe infertility.
INTRODUCTION
Infertility is a global health problem affecting 10-15% of couples at reproductive age and in half of these cases, a male causal factor can be identified [1] [2] [3] [4] [5] . It is estimated that about 7% of all men have problems with their fertility [6] . Male infertility is a complex disease, and several factors have been involved in etiology of the disorder: endocrine abnormalities, infections, environmental exposure, genetic defects and others. However, in 30-40% of these cases, no specific cause could be found [1, 4] .
Genetic abnormalities are thought to play an important role in multifactorial etiology of the disorder, accounting for 10-15% of severe male infertility, including chromosomal aberations and single gene mutations [3, 6] . Among genetic disorders are hypogonadotropic hypogonadism, mutations in the androgen receptor, cystic fibrosis gene mutations, genetic polymorphisms and Y chromosome linked infertility. Chromosomal anomalies are the most common genetic causes of male infertility found about 10 times more frequently in infertile men (4-16%) than in the general population (0.4%) [4, 6] . The microdeletions of azoospermia factor (AZF) region in the Y chromosome are considered as the most frequent known molecular-genetic cause of severe impairment of spermatogenesis, detected in about 10% of men with non-obstructive azoospermia and 3-5% of men with idiopatic severe oligozoospermia [6] .
Aim:
In order to evaluate the proportion of the most common genetic defects in etiology of severe male infertility we investigated the frequency of chromosomal abnormalities and Y chromosome microdeletions in Bulgarian males with azoospermia or severe oligozoospermia.
MATERIAL AND METHODS Patients
The current study was retrospective, based on the data of the Section of Medical Genetic, Medical University of Pleven (for the period 2007-2016) and included men with infertility, candidates for ART, referred for genetic counseling and genetic testing after preliminary examina-tions to exclude some more frequent causes for male infertility disorders (systemic diseases, exogenous factors, endocrine abnormalities, infections, varicocele, cryptorchidisum, erectile and other urological abnormalities). A total of 142 Bulgarian males with severe infertility (63 patients with non-obstructive azoospermia and 79 patients with severe oligozoospermia /sperm count < 5×10 6 / ml) were selected and included in the study. Cytogenetic analysis was carried out in 137 men (58 patients with azoospermia and 79 patients with severe oligozoospermia ). Molecular screening of AZF region microdeletions of Y chromosome was carried out in 109 men (63 patients with azoospermia and 46 patients with severe oligozoospermia). Both karyotyping and molecular analysis were performed in 104 men (58 with azoospermia and 46 with oligozoospermia). Written informed consent from each patient was obtained.
Chromosomal analysis
Cytogenetic study via conventional GTG-banding was carried out on phyto-haemaglutinin stimulated peripheral blood lymphocytes with analysis of at least 30 metaphases/per individual (resolution of 400-550 band/ haploid set). The detected chromosomal abnormalities (CA) were reported in accordance with ISCN, 2009.
Molecular analysis
The study of Yq chromosome microdeletions (delYq) was performed by multiplex PCR using primers for amplification of six sequence-tagged sites from the AZF region on Yq11, including sY84 and sY86 (AZFa), sY127 and sY134 (AZFb), sY254 and sY255 (AZFc). In addition, amplification of a pseudoautosomal region of Y chromosome (ZFY) and SRY (sY14) gene was used as internal control. Fertile male, female samples and deionizied water were used as positive, negative and blank controls, respectively. Size of amplification products is as follow: ZFY -495 bp, SRY -472 bp, sY254 -400 bp, sY255 -126 bp, sY84 -320 bp, sY86 -326 bp, sY134 -301 bp, sY127 -274 bp. The two multiplex PCR reactions were designed -A and B (Table 1 ). The reagents used to carry out the amplification reactions for the tested markers are presented in Table  2 . PCR samples were analyzed on 2% agarose gel, stained with ethidium bromide, and visualized using ultraviolet transillumination. The samples that were detected to have a deletion were additionally confirmed by another PCR. 
RESULTS
Cytogenetic analysis showed that of 137 infertile men studied, 114 men (83.2%) had a normal karyotype and 23 men had (16.8%) abnormal karyotype. The frequencies of CA in two subgroups were: 20.7% (12/58) in patients with azoospermia and 13.9% (11/79) in patients with oligozoospermia. The detected CAs are presented in Table 3 . Sex CAs were found in 12 (8.8%) of all tested men: 6 (13.8%) male with azoospermia and 3 men with oligozoospermia. Klinefeltar syndrome is the most frequent (75%) of sex chromosome anomaly, established in 9 (6.5%) of a total studied infertile men (6 men with azoospermia and 3 men with oligozoospermia). Autosomal CAs in the form of balanced chromosomal rearrangements (including 8 cases of translocations, 2 cases of inversions, and one polymorphism) were established in 11 (8%) of all infertile patients. In the current study of 109 studied infertile men, delYq were established in 6 (5.5%) men, all of them with azoospermia (Table 4) . Among these patients, three had deletions of AZFc, two had deletions of AZFb, and one had a deletion of AZFb+AZFc. In the last patient, delY If the frequencies of CA and delYq, established in our study, were 16.8% and 5.5% respectively, the overall proportion of these genetic defects that we found in etiology of severe male infertility would be 22.3%. The proportion of two genetic causes was higher 30.2% in a subgroup of males with azoospermia and 13.9% in males with oligozoospermia.
DISCUSSION
Chromosomal abnormalities and Y chromosome microdeletions are considered to be the most common genetic causes of male infertility [7] . Based on the published [PubMed] [Crossref] 4. Suganthi R, Vijesh VV, Vandana N, Fathima Ali Benazir J. Y choromosomal microdeletion screening in in literature data, the overall frequency of CA in infertile males widely ranges from 2% to 28% (only 0.7%-1% in general male population) and the variation is mainly the result of different study design, patient group, ethnic background and others factors [4, [7] [8] [9] [10] [11] [12] . The review articles of Ferlin A. 2007 [13] and O'Flynn 2010 [2] estimate that the overall frequency ranges between 2% and 8-10% (with an average value of 5%) and increases up to 15% in azoospermic males.
In our study, CAs were found in 16.8% of all investigated infertile men and 20.7% in the subgroup of patients with azoospermia. We established an overall frequency of CA that is similar to that reported in other studies [11, 12] (11.6% and 22% respectively) with a desigh similar to ours. The much higher frequencies in our study may be are due to the preliminary selection of the studied patients: men with severe infertility (azoospermia or severe oligozoospermia) and exclusion in advance of more common non-genetic causes, factors that increase the probability to detect genetic causal factors for infertility.
In accordance with the literature [2, 8, 9, 13], in our study sex, CAs were more frequent in a subgroup of males with azoospermia 13.8%, and Klinefeltar syndrome had the highest frequency of 10.3%. The other CAs found in our cases with severe male infertility were balanced autosomal rearrangements more common established among oligozoospermic men 8.9%. Along with fertile problems, CAs are associated with risk for abnormal offspring, therefore genetic counseling is recommended in all cases of detected CA in men.
Microdeletions of Y chromosome we detected in 5.5% of all tested infertile men and up to 9.5% in the subgroup of azoospermic men. The most common were deletions of AZFc region, in consistence with the literature [2, 4, 6, 10, 11, 14] .
The overall frequency of delYq varies from 1 to 58% in different published studies. The frequency of delY is about 15-20% in azoospermic cases, 5-10% in cases with idiopathic severe oligizoospermia and 2-3% in men candidates for ICSI [4, 13] . The variation in reported frequencies could be due to different patients selection criteria, sample size, used STS primers, ethical and geographical difference, other additional genetic backgrounds, environmental influences. Higher frequencies were found in studies using strict criteria for selection of patients, males with severe infertility as well as the study of cases with the preliminary exclusion of other more frequently causes for infertility disorder [2, 4, 7, 9, 13, 11 -15] .
Genetic abnormalities are thought to contribute to 15%-30% of severe male infertility [1, 3] . In our study, the overall proportion of the two most common genetic factors (CA and delYq) was higher 30% in patients with azoospermia and 14% in men with oligozoospermia. The established overall proportion of genetic factors of 22% in cases of Bulgarian men with severe infertility is similar to the reported of Fu L. et al. 2012 [11] , and Dada R. et al., 2006 [12] (19.8% and 26.7% respectively) in studies with design similar to ours. CONCLUSION · Chromosomal abnormalities and Yq microdeletions are important genetic factors in etiology of male infertility, accounting for about 22% of cases with severe infertility in Bulgarian men.
· Use of strict criteria for selection of the study group of infertile male increase the chance to find a genetic cause for infertility.
· Genetic testing should be a routine part of examinations in infertile males, providing helpful information about the cause of the problem and how to deal with it.
· Genetic counseling, in cases with identified genetic causes, allows assessment of possible genetic risks and provides an opportunity for the best choice of appropriate technique for assisted reproduction of the couple.
